Kedrion Biopharma
Ferdinando Borgese has a diverse work experience spanning multiple industries. Ferdinando started their career as a Sales Representative for the metabolic and cardiovascular portfolio at Guidotti by Menarini Group in 2001. In 2002, they transitioned to become a Cardiovascular Brand Manager within the same company. In 2005, Borgese joined GSK as a Senior Brand Manager for the metabolic and cardiovascular portfolio. In 2007, they moved to Novartis Vaccines and Diagnostics, where they served as a Global Brand Manager. During their time there, they were responsible for managing the Human Rabies vaccine and Tick Borne Encephalitis vaccine. Borgese also collaborated with various organizations to develop disease eradication strategies. In 2011, they joined AstraZeneca as a Brand Leader for Crestor. In 2012, Borgese became the International Marketing Director at Kedrion Biopharma. Ferdinando gradually progressed within the company, taking on roles such as Head of Global Marketing, Head of Global Marketing and Commercial Operation Asia, Director of Commercial Operations Asia, Middle East and Africa, and Commercial Director Intercontinental. Since 2023, Borgese has been serving as the Vice President, Commercial Intercontinental Region, ICM / Toll Manufacturing at Kedrion Biopharma. Additionally, they hold the position of Chairman of the EU Board at the Plasma Protein Therapeutics Association (PPTA).
Ferdinando Borgese attended Università degli Studi di Firenze, where they studied Biology Science. The duration of their education is unknown.
This person is not in any offices
Kedrion Biopharma
19 followers
Kedrion Biopharma is a biopharmaceutical company that collects and fractionates blood plasma to produce and distribute worldwide plasma-derived therapies for use in treating and preventing rare and serious diseases and conditions. In 2022, Kedrion joined forces with BPL (Bio Products Laboratory). Based in the United Kingdom, BPL has over 60 years of experience in the supply of high-quality plasma-derived medicines to treat rare diseases. Kedrion distributes its products in over 100 countries around the world. We have plants in Italy, Hungary, UK and North America, and plasma collection centers in the US and in the Czech Republic. With these figures we are the world’s 5th top player in the field of plasma-derived products. Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us. Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth. Kedrion builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.